The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
siena biotech | 334 |
roche | 242 |
wyeth | 33 |
wyeth pharmaceuticals | 4 |
teva pharmaceutical industries | 3 |
siena biotech | 26 |
wyeth | 10 |
roche | 5 |
wyeth pharmaceuticals | 1 |
roche | 3 |
teva pharmaceutical industries | 2 |
siena biotech | 2 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
fluoromethyl-5,6-dihydro-4h-[1,3]oxazines | 34 | 2012 |
2-amino-5, 5-difluoro-5, 6-dihydro-4h-oxazines as bace 1 and/or bace 2 inhibitors | 27 | 2009 |
nicotinic acetylcholine receptor modulators | 24 | 2007 |
processes for the preparation of 6-chloro-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide … 🛈 | 23 | 2011 |
1,3 oxazines as bace1 and/or bace2 inhibitors | 23 | 2011 |
bace1 inhibitors | 21 | 2013 |
halogen-alkyl-1,3 oxazines as bace1 and/or bace2 inhibitors | 20 | 2011 |
hedgehog pathway antagonists and therapeutic applications thereof | 20 | 2007 |
1,3-oxazines as bace1 and/or bace2 inhibitors | 19 | 2011 |
2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine… 🛈 | 18 | 2010 |